Status: Phase 2
Entry Type: Unknown
Molecule Category: UNKNOWN

Indications

Mesh Heading Maximum Phase Reference
Ischemia; Stroke Phase 1/Phase 2 ClinicalTrials
Vitreous Detachment Phase 2 ClinicalTrials
Vitreous Detachment Phase 1/Phase 2 ClinicalTrials
Arterial Occlusive Diseases; Thrombosis Phase 2 ClinicalTrials
CONTENTS